Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Digital Therapeutics: Everything You Need to Know
Summary
In this episode, Tom Caravela welcomes Madleine Makori to discuss her career journey and passion for the MSL role, with a particular focus on digital therapeutics. Madleine shares insights into the differentiation and challenges of digital therapeutics and how COVID-19 has accelerated technology adaptation for patient populations. The conversation delves into the growing collaborations in digital therapeutics and the increasing provider interest in this field. Madleine highlights expanding opportunities for MSLs in tech and the importance of education in this evolving area. The episode concludes with an invitation for audience engagement and a call to subscribe.
Madleine Makori, Sr Medical Science Liaison at Big Health discusses everything you need to know about Digital Therapeutics
Maddy explains…
👉 What is Digital Therapeutics and how it differs from wellness and lifestyle apps
👉 How Digital Therapeutics is making an impact on the pharmaceutical industry
👉 The impact of Covid-19 and the development of the space
👉 What opportunities may emerge and what it means for Medical Affairs
👉 What the future looks like for the Digital Therapeutics space and what people need to know
Digital Therapeutics, Medical Science Liaison, COVID-19 technology adaptation, opportunities in tech for MSLs, future of Digital Therapeutics
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Value assessment of oncology drugs using a weighted criterion-based approach
Article
Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
Article
Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD